Association of Levetiracetam Exposure With Behavioral Symptoms,  Depression, Anxiety, and Medication Adherence Among Adults With Epilepsy:  A Cross-Sectional Study

Asad Minhas, Masood Uz Zaman Babar, Nadeem Raza, Faraz Ahmed, Sana Imran, Qudsum Yousaf

Association of Levetiracetam Exposure With Behavioral Symptoms, Depression, Anxiety, and Medication Adherence Among Adults With Epilepsy: A Cross-Sectional Study

Authors

Asad Minhas, Masood Uz Zaman Babar, Nadeem Raza, Faraz Ahmed, Sana Imran, Qudsum Yousaf

Keywords:

Levetiracetam, epilepsy, behavioral adverse effects, irritability, depression, anxiety, medication adherence, antiseizure medication, pharmacovigilance, neurology.

Abstract

Background: Levetiracetam is widely usedin the pharmacological management ofepilepsy because of its broad antiseizure efficacy, relatively favorablepharmacokinetic profile, and limitedpotential for pharmacokinetic druginteractions.

References

1. Cramer JA, De Rue K, Devinsky O, Edrich P, Trimble MR. A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy & Behavior. 2003;4(2):124–132. doi:10.1016/S1525-5050(03)00005-2.

Downloads

Published

2026-10-15

How to Cite

Asad Minhas, Masood Uz Zaman Babar, Nadeem Raza, Faraz Ahmed, Sana Imran, Qudsum Yousaf. (2026). Association of Levetiracetam Exposure With Behavioral Symptoms, Depression, Anxiety, and Medication Adherence Among Adults With Epilepsy: A Cross-Sectional Study. International Journal of Pharmacy Research & Technology (IJPRT), 16(2), 6459–6472. Retrieved from https://www.ijprt.org/index.php/pub/article/view/3358